“…For that reason, the main interest is paid to Pd(II), mainly due to the evident structural analogy between Pt(II) and Pd(II) complexes. Other derivatives of cis-[Pd(L) 2 Cl 2 ] have been described, where L = pyrazole [21], triazolopyrimidine [22] or inosine derivatives [23], with significant antitumour activity. Many trans-[Pd(L) 2 been published, where L = 2,6-dimethyl-4-nitropyridine [24], pyrazole [21], aminobenzonitrile [25], inosine, guanosine, adenosine, xanthosine [23,26] or 6-benzylaminopurine derivatives [18,27,28], with moderate anticancer properties.…”